+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glaucoma Surgery Devices - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 105 Pages
  • November 2021
  • Region: Global
  • GlobalData
  • ID: 5505133
Description Jump to:
The publisher's Medical Devices sector report, “Glaucoma Surgery Devices - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. Glaucoma Surgery Devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule form about 4-6 weeks after surgery and regulates flow.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Glaucoma Surgery Devices Overview
3 Products under Development
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials
4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
5 Glaucoma Surgery Devices Companies and Product Overview
5.1 Alievio Inc Company Overview
5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allergan Ltd Company Overview
5.2.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Assenti, LLC Company Overview
5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Avisi Technologies LLC Company Overview
5.4.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Corneat Vision Ltd Company Overview
5.5.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Eye Sonix Company Overview
5.6.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
5.7 Galaxy Ophthalmics Inc (Inactive) Company Overview
5.7.1 Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Geuder AG Company Overview
5.8.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
5.9 Glaukos Corp Company Overview
5.9.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 InnFocus Inc Company Overview
5.10.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 iScience Interventional Inc Company Overview
5.11.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 iSTAR Medical SA Company Overview
5.12.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.13 iVeena Delivery Systems Inc Company Overview
5.13.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Johns Hopkins University Company Overview
5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kytogenics Pharmaceuticals Inc Company Overview
5.15.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Meir Medical Center Company Overview
5.17.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.18 Merz Anteis SA Company Overview
5.18.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
5.19 MicroOptx Inc Company Overview
5.19.1 MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Myra Vision Inc Company Overview
5.20.1 Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Ocumatrx Company Overview
5.21.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
5.22 OcuTherix Inc Company Overview
5.22.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 OPKO Health Inc Company Overview
5.23.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 OptoLight Vision Technology Company Overview
5.24.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
5.25 Purdue University Company Overview
5.25.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Quantel Medical SA Company Overview
5.26.1 Quantel Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.27 Queen's University Company Overview
5.27.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview
5.28 Rheon Medical SA Company Overview
5.28.1 Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.29 Sheba Medical Center Company Overview
5.29.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.30 Sight Sciences Inc Company Overview
5.30.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 SOLX Inc Company Overview
5.31.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Tel Aviv University Company Overview
5.32.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.33 University of Colorado Company Overview
5.33.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.34 University of Michigan Company Overview
5.34.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.35 Westhouse Medical Services Plc (Inactive) Company Overview
5.35.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Glaucoma Surgery Devices- Recent Developments
6.1 Nov 04, 2021: Glaukos Announces Third Quarter 2021 Financial Results
6.2 Oct 26, 2021: Nova Eye Medical: US government stimulus loan forgiven
6.3 Sep 28, 2021: Ocular Therapeutix Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations
6.4 Sep 22, 2021: Ocular Therapeutix Appoints Merilee Raines to Its Board of Directors
6.5 Sep 13, 2021: Ocular Therapeutix Updates Monthly In-Market Unit Sales of DEXTENZA Billable Inserts
6.6 Aug 26, 2021: Glaukos Announces Participation in the Wells Fargo Healthcare Conference
6.7 Aug 10, 2021: Ocular Therapeutix to Present at the H.C. Wainwright Ophthalmology Virtual Conference
6.8 Aug 09, 2021: Ocular Therapeutix Reports Second Quarter 2021 Financial Results and Business Update
6.9 Aug 05, 2021: Glaukos Announces Second Quarter 2021 Financial Results
6.10 Jul 29, 2021: OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results
6.11 Jul 28, 2021: Ocular Therapeutix To Report Second Quarter 2021 Financial Results
6.12 Jul 22, 2021: Ocular Therapeutix Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
6.13 Jul 21, 2021: STAAR Surgical to Report Second Quarter Results on August 4, 2021
6.14 Jul 20, 2021: OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
6.15 Jul 15, 2021: Glaukos to Release Second Quarter 2021 Financial Results after Market Close on August 5
6.16 Jul 14, 2021: Glaukos comments on the Centers for Medicare and Medicaid Services 2022 proposed physician fee schedule
6.17 May 05, 2021: Glaukos Announces First Quarter 2021 Financial Results
6.18 Apr 28, 2021: Ocular Therapeutix To Report First Quarter 2021 Financial Results
6.19 Apr 21, 2021: STAAR Surgical to Report First Quarter Results on May 5, 2021
6.20 Mar 11, 2021: Ocular Therapeutix reports fourth quarter and year end 2020 financial results and business update
6.21 Mar 02, 2021: Glaukos Announces Participation in Oppenheimer Healthcare Conference
6.22 Mar 01, 2021: Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors
6.23 Feb 25, 2021: Ocular Therapeutix To Report Fourth Quarter and Year End 2020 Financial Results
6.24 Feb 24, 2021: Ocular Therapeutix to Participate at Three Upcoming Investor Conferences
6.25 Feb 24, 2021: 02.24.2021 STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results
6.26 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees
6.27 Feb 18, 2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
6.28 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil
6.29 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.30 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.31 Feb 10, 2021: STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
List of Tables
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Segment
Glaucoma Surgery Devices - Pipeline Products by Territory
Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Glaucoma Surgery Devices - Ongoing Clinical Trials
Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
Camras Shunt - Product Status
Camras Shunt - Product Description
Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
XEN63 - Product Status
XEN63 - Product Description
Allergan Ltd - Ongoing Clinical Trials Overview
XEN63 - Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) with or without Mitomycin C
Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
Intraocular Pressure Monitoring System - Product Status
Intraocular Pressure Monitoring System - Product Description
Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
VisiPlate - Product Status
VisiPlate - Product Description
Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
CorNeat eShunt - Product Status
CorNeat eShunt - Product Description
Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
Therapeutic Ultrasound Device - Glaucoma - Product Status
Therapeutic Ultrasound Device - Glaucoma - Product Description
Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Titan Shunt - Product Status
Titan Shunt - Product Description
Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Microsystem Implant - Product Status
Microsystem Implant - Product Description
Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
iStent Infinite Trabecular Micro-Bypass System - Product Status
iStent Infinite Trabecular Micro-Bypass System - Product Description
iStent SA Trabecular Micro-Bypass System - Product Status
iStent SA Trabecular Micro-Bypass System - Product Description
iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status
iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description
Glaukos Corp - Ongoing Clinical Trials Overview
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery
iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject)
iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin
iStent SA Trabecular Micro-Bypass System - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject
iStent SA Trabecular Micro-Bypass System - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
iStent Infinite Trabecular Micro-Bypass System - A Prospective, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass System, Model iS3, in Subjects with Refractory Glaucoma
InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
PreserFlo MicroShunt - Product Status
PreserFlo MicroShunt - Product Description
InnFocus Inc - Ongoing Clinical Trials Overview
PreserFlo MicroShunt - A Prospective, Concurrent Controlled, Open-label, Multicenter Clinical Study to Assess the Long-term Safety of the PRESERFLO MicroShunt in Subjects with Primary Open-angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study
PreserFlo MicroShunt - Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas
PreserFlo MicroShunt - Evaluation of Minimal Invasive Glaucoma Surgery: Trabeculectomy Vs. Xen Vs. Preserflo Randomized Clinial Trial
PreserFlo MicroShunt - Intraocular Pressure after Preserflo /Innfocus Microshunt Vs Trabeculectomy: A Prospective, Randomized Control-trial (PAINT-Study)
PreserFlo MicroShunt - SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE)
PreserFlo MicroShunt - Vienna Preserflo Microshunt Cohort Study
iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
Glaucoma Device - Product Status
Glaucoma Device - Product Description
iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
MINIject - Product Status
MINIject - Product Description
STARflo MINI - Product Status
STARflo MINI - Product Description
STARflo Plus Glaucoma Implant - Product Status
STARflo Plus Glaucoma Implant - Product Description
iSTAR Medical SA - Ongoing Clinical Trials Overview
MINIject - A Prospective, Open, Clinical Trial Analysing the Efficacy and Safety of Miniject (MINI SO627) in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications Using a Single Operator Delivery Tool
MINIject - A Prospective, Open, Multicenter Clinical Trial Analysing the Effectiveness and Safety of MINIject 636 in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
MINIject - A Prospective, Open, Multicenter Clinical Trial Analyzing the Efficacy and Safety of Miniject (MINI SO627) in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications Using a Single Operator Delivery Tool
MINIject - A Prospective, Open, Multicenter Clinical Trial with One Cohort Analyzing the Efficacy and Safety of MINIject in European Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
MINIject - A Prospective, Open, Multicenter Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
MINIject - Safety and Efficacy Study of MINIject in Patients with Primary Open Angle Glaucoma: A Pivotal Trial
iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
IVMED-70 - Product Status
IVMED-70 - Product Description
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Partially Degradable Glaucoma Stent - Product Status
Partially Degradable Glaucoma Stent - Product Description
Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
MACC-Based Device - Glaucoma Filtering - Product Status
MACC-Based Device - Glaucoma Filtering - Product Description
Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
CellPlant Aqueous Stent - Product Status
CellPlant Aqueous Stent - Product Description
Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Glaucoma Drainage Device - Product Status
Glaucoma Drainage Device - Product Description
Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
Drainage Viscoelastic Injectable Implant - Product Status
Drainage Viscoelastic Injectable Implant - Product Description
MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview
Brown Glaucoma Implant (BGI) - Product Status
Brown Glaucoma Implant (BGI) - Product Description
MicroOptx Inc - Ongoing Clinical Trials Overview
Brown Glaucoma Implant (BGI) - A Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of Beacon Aqueous Microshunt for Refractory Glaucoma: The Beacon Study
Brown Glaucoma Implant (BGI) - Early Evaluation of the Brown Glaucoma Implant in Patients Refractory to Drug Therapy in the European Union
Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
Calibreye - Product Status
Calibreye - Product Description
Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
CaPRI Device - Product Status
CaPRI Device - Product Description
OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
Deep Wave Trabeculoplasty Device - Product Status
Deep Wave Trabeculoplasty Device - Product Description
OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Aquashunt - Product Status
Aquashunt - Product Description
OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
Lipshitz Macular Implant - Advanced Glaucoma - Product Status
Lipshitz Macular Implant - Advanced Glaucoma - Product Description
Purdue University Pipeline Products & Ongoing Clinical Trials Overview
Smart Drainage Device - Glaucoma - Product Status
Smart Drainage Device - Glaucoma - Product Description
Quantel Medical SA Pipeline Products & Ongoing Clinical Trials Overview
SubCyclo Probe - Product Status
SubCyclo Probe - Product Description
Queen's University Pipeline Products & Ongoing Clinical Trials Overview
Laser Adjustable Suture - Product Status
Laser Adjustable Suture - Product Description
Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview
eyeWatch System - Product Status
eyeWatch System - Product Description
Rheon Medical SA - Ongoing Clinical Trials Overview
eyeWatch System - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
eyeWatch System - Randomized Control Trial of the eyeWatch System as a First-line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy
Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Toroidal Glaucoma Drainage Device - Product Status
Toroidal Glaucoma Drainage Device - Product Description
Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Status
VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Description
SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
SOLX Gold Shunt - Product Status
SOLX Gold Shunt - Product Description
Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
Direct Laser Trabeculoplasty System - Product Status
Direct Laser Trabeculoplasty System - Product Description
Glaucoma Implant - Product Status
Glaucoma Implant - Product Description
University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
Aqueous Humor Micro-Bypass Shunt - Product Status
Aqueous Humor Micro-Bypass Shunt - Product Description
Glaucoma Device - Product Status
Glaucoma Device - Product Description
University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Integrated Magnetoelastic Actuator - Product Status
Integrated Magnetoelastic Actuator - Product Description
Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Pneumatic Trabeculoplasty System - Product Status
Pneumatic Trabeculoplasty System - Product Description
Glossary
List of Figures
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Segment
Glaucoma Surgery Devices - Pipeline Products by Territory
Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Glaucoma Surgery Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alievio Inc
  • Allergan Ltd
  • Assenti, LLC
  • Avisi Technologies LLC
  • Corneat Vision Ltd
  • Eye Sonix
  • Galaxy Ophthalmics Inc (Inactive)
  • Geuder AG
  • Glaukos Corp
  • InnFocus Inc
  • iScience Interventional Inc
  • iSTAR Medical SA
  • iVeena Delivery Systems Inc
  • Johns Hopkins University
  • Kytogenics Pharmaceuticals Inc
  • Medtronic Plc
  • Meir Medical Center
  • Merz Anteis SA
  • MicroOptx Inc
  • Myra Vision Inc
  • Ocumatrx
  • OcuTherix Inc
  • OPKO Health Inc
  • OptoLight Vision Technology
  • Purdue University
  • Quantel Medical SA
  • Queen's University
  • Rheon Medical SA
  • Sheba Medical Center
  • Sight Sciences Inc
  • SOLX Inc
  • Tel Aviv University
  • University of Colorado
  • University of Michigan
  • Westhouse Medical Services Plc (Inactive)

Related Topics

Related Reports

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Image

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • 121 Pages
  • Global
From
Global Glaucoma Surgery Devices Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Glaucoma Surgery Devices Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 189 Pages
  • Global
From
Global Glaucoma Surgery Devices Market Report and Forecast 2024-2032 - Product Image

Global Glaucoma Surgery Devices Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Glaucoma Surgery Devices Global Market Report 2024 - Product Image

Glaucoma Surgery Devices Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Glaucoma Surgery Devices Market by Product (Algerbrush, Diamond Knives, Forceps), Surgery Method (Laser Surgery, Minimal Invasive Glaucoma Surgery, Traditional Glaucoma Surgery), End-User - Forecast 2024-2030 - Product Image

Global Glaucoma Surgery Devices Market by Product (Algerbrush, Diamond Knives, Forceps), Surgery Method (Laser Surgery, Minimal Invasive Glaucoma Surgery, Traditional Glaucoma Surgery), End-User - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.